The FDA greenlights a booster shot for immunocompromised people; the UK has its first mass shooting since 2010.
Tonight's Sentences was written by Gabby Birenbaum.
A Covid booster shot for the immunocompromised Ariana Drehsler/AFP/Getty Images
Six dead in British mass shooting
The US military is sending thousands of troops to Kabul to help evacuate civilians from the city's American Embassy in advance of the anticipated Taliban capture of the Afghan capital. [Politico / Quint Forgey, Nahal Toosi, and Alexander Ward]
Support our journalism Reader contributions help keep Vox and newsletters like Sentences free for all. Support our work from as little as $3.
What's the name of a Kennedy Center honoree's award?
"Inevitably, there will be a time when we'll have to give boosts. What we're doing, literally, on a weekly and monthly basis is following cohorts of patients to determine if, when and whom should get it."
Matt is joined by reporter Spencer Ackerman, author of the new book Reign of Terror. They discuss the treatment of Timothy McVeigh after the Oklahoma City bombing, and how it primed the political and cultural response to 9/11 and the war on terror. Ackerman also argues that the unlawful and immoral approach of the government laid the groundwork for Trump's presidency. [Spotify]
This email was sent to edwardlorilla1986.paxforex@blogger.com. Manage your email preferences or unsubscribe. If you value Vox's unique explanatory journalism, support our work with a one-time or recurring contribution.
View our Privacy Notice and our Terms of Service.
Vox Media, 1201 Connecticut Ave. NW, Floor 11, Washington, DC 20036. |
Friday, August 13, 2021
The first FDA-approved booster
Subscribe to:
Post Comments (Atom)
New American Pipeline Is Pumping 890,000 Barrels of Oil Per Day!
For your weekend reading, we bring you the week's most popular stories from Energy and Capital and our sister site, Wealth Daily… ͏ ͏ ...
-
insidecroydon posted: " Become a Patron! What's on inside Croydon: Click here for the latest events listing...
No comments:
Post a Comment